Simon Cervenka - Publications

Karolinska Institute, Stockholm, Sweden 
psychiatry, neuroimaging

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, ... ... Cervenka S, et al. Common brain disorders are associated with heritable patterns of apparent aging of the brain. Nature Neuroscience. 22: 1617-1623. PMID 31551603 DOI: 10.1038/s41593-019-0471-7  0.52
2019 Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J. Validity and reliability of extrastriatal [C]raclopride binding quantification in the living human brain. Neuroimage. 116143. PMID 31473354 DOI: 10.1016/j.neuroimage.2019.116143  1
2019 Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, ... ... Cervenka S, et al. Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [C]PBR28 HRRT PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31363804 DOI: 10.1007/s00259-019-04403-7  1
2019 Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, et al. Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. Jama Psychiatry. PMID 30969333 DOI: 10.1001/jamapsychiatry.2019.0257  0.52
2019 Stenkrona P, Matheson GJ, Halldin C, Cervenka S, Farde L. D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients. The International Journal of Neuropsychopharmacology. PMID 30958880 DOI: 10.1093/ijnp/pyz017  1
2019 Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Carlo PD, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, ... ... Cervenka S, et al. Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder. Translational Psychiatry. 9: 12. PMID 30664633 DOI: 10.1038/s41398-018-0225-4  0.52
2019 Malmqvist A, Schwieler L, Orhan F, Fatouros-Bergman H, Bauer M, Flyckt L, Cervenka S, Engberg G, Piehl F, Erhardt S. Increased peripheral levels of TARC/CCL17 in first episode psychosis patients. Schizophrenia Research. PMID 30612841 DOI: 10.1016/j.schres.2018.12.033  0.52
2018 Caravaggio F, Plavén-Sigray P, Matheson GJ, Plitman E, Chakravarty MM, Borg J, Graff-Guerrero A, Cervenka S. Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men. Plos One. 13: e0209584. PMID 30571791 DOI: 10.1371/journal.pone.0209584  1
2018 Plaven-Sigray P, Schain M, Zanderigo F, Rabiner I, Gunn R, Ogden T, Cervenka S. Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region. Neuroimage. PMID 30500425 DOI: 10.1016/j.neuroimage.2018.11.020  0.52
2018 Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S. Test-retest reliability and convergent validity of (R)-[C]PK11195 outcome measures without arterial input function. Ejnmmi Research. 8: 102. PMID 30498919 DOI: 10.1186/s13550-018-0455-8  1
2018 Griffioen G, Matheson GJ, Cervenka S, Farde L, Borg J. Serotonin 5-HT receptor binding and self-transcendence in healthy control subjects-a replication study using Bayesian hypothesis testing. Peerj. 6: e5790. PMID 30479884 DOI: 10.7717/peerj.5790  1
2018 Albrecht DS, Forsberg A, Sandstrom A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Höglund CO, Catana C, Cervenka S, Akeju O, Lekander M, Cohen G, Halldin C, et al. Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain, Behavior, and Immunity. PMID 30223011 DOI: 10.1016/j.bbi.2018.09.018  1
2018 Stenkrona P, Matheson GJ, Cervenka S, Sigray PP, Halldin C, Farde L. [C]SCH23390 binding to the D-dopamine receptor in the human brain-a comparison of manual and automated methods for image analysis. Ejnmmi Research. 8: 74. PMID 30069645 DOI: 10.1186/s13550-018-0416-2  1
2018 Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data. Biological Psychiatry. PMID 29653835 DOI: 10.1016/j.biopsych.2018.02.1171  1
2018 Checa A, Malmqvist A, Flyckt L, Schwieler L, Samuelsson M, Skogh E, Cervenka S, Dahl ML, Piehl F, Erhardt S, Wheelock CE. Cerebrospinal fluid levels of sphingolipids associate with disease severity in first episode psychosis patients. Schizophrenia Research. PMID 29627172 DOI: 10.1016/j.schres.2018.03.029  0.52
2018 Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L, Cervenka S. Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study. Plos One. 13: e0193770. PMID 29543812 DOI: 10.1371/journal.pone.0193770  1
2018 Farde L, Plavén-Sigray P, Borg J, Cervenka S. Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 373. PMID 29483342 DOI: 10.1098/rstb.2017.0156  1
2017 Tamm S, Cervenka S, Forsberg A, Estelius J, Grunewald J, Gyllfors P, Karshikoff B, Kosek E, Lampa J, Lensmar C, Strand V, Åkerstedt T, Halldin C, Ingvar M, Höglund CO, et al. Evidence of fatigue, disordered sleep and peripheral inflammation, but not increased brain TSPO expression, in seasonal allergy: A [(11)C]PBR28 PET study. Brain, Behavior, and Immunity. PMID 29054675 DOI: 10.1016/j.bbi.2017.10.013  1
2017 Orhan F, Fatouros-Bergman H, Schwieler L, Cervenka S, Flyckt L, Sellgren CM, Engberg G, Erhardt S. First-episode psychosis patients display increased plasma IL-18 that correlates with cognitive dysfunction. Schizophrenia Research. PMID 28951075 DOI: 10.1016/j.schres.2017.09.016  0.52
2017 Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S. Assessment of simplified ratio-based approaches for quantification of PET [(11)C]PBR28 data. Ejnmmi Research. 7: 58. PMID 28733954 DOI: 10.1186/s13550-017-0304-1  1
2017 Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S. Reliability of Volumetric and Surface-Based Normalisation and Smoothing Techniques for PET Analysis of the Cortex: A Test-Retest Analysis using [(11)C]SCH-23390. Neuroimage. PMID 28419852 DOI: 10.1016/j.neuroimage.2017.04.031  1
2017 Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S. Extrastriatal dopamine D2-receptor availability in social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28377075 DOI: 10.1016/j.euroneuro.2017.03.007  1
2017 Forsberg A, Cervenka S, Jonsson Fagerlund M, Rasmussen LS, Zetterberg H, Erlandsson Harris H, Stridh P, Christensson E, Granström A, Schening A, Dymmel K, Knave N, Terrando N, Maze M, Borg J, et al. The immune response of the human brain to abdominal surgery. Annals of Neurology. PMID 28253549 DOI: 10.1002/ana.24909  1
2016 Kanegawa N, Collste K, Forsberg A, Schain M, Arakawa R, Jucaite A, Lekander M, Höglund CO, Kosek E, Lampa J, Halldin C, Farde L, Varrone A, Cervenka S. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain, Behavior, and Immunity. PMID 26820224 DOI: 10.1016/j.bbi.2016.01.019  1
2015 Borg J, Cervenka S, Kuja-Halkola R, Matheson GJ, Jönsson EG, Lichtenstein P, Henningsson S, Ichimiya T, Larsson H, Stenkrona P, Halldin C, Farde L. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain. Molecular Psychiatry. PMID 26821979 DOI: 10.1038/mp.2015.147  1
2015 Schalling M, Engberg G, Andreassen O, Erhardt S, Cunningham J, Agartz I, Petrovic P, Cervenka S, Fatouros-Bergman H. [In Process Citation]. LäKartidningen. 112. PMID 26461505  0.52
2015 Collste K, Forsberg A, Varrone A, Amini N, Aeinehband S, Yakushev I, Halldin C, Farde L, Cervenka S. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26293827 DOI: 10.1007/s00259-015-3149-8  1
2015 Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljótsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Rück C. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. Jama Psychiatry. 72: 659-67. PMID 25970252 DOI: 10.1001/jamapsychiatry.2015.0546  1
2015 Guterstam J, Hammarberg A, Finn SW, Cervenka S, Lekander M, Petrovic P, Hedman E. [In Process Citation]. LäKartidningen. 112. PMID 25781592  0.36
2015 Matheson GJ, Schain M, Almeida R, Lundberg J, Cselényi Z, Borg J, Varrone A, Farde L, Cervenka S. Diurnal and seasonal variation of the brain serotonin system in healthy male subjects. Neuroimage. 112: 225-31. PMID 25772667 DOI: 10.1016/j.neuroimage.2015.03.007  1
2015 van der Doef TF, Doorduin J, van Berckel BNM, Cervenka S. Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein Clinical and Translational Imaging. 3: 449-460. DOI: 10.1007/s40336-015-0140-0  1
2015 Schalling M, Engberg G, Andreassen OA, Erhardt S, Cunningham J, Agartz I, Petrovic P, Cervenka S, Fatouros-Bergman H. Nya rön om schizofreni kan ge ny diagnostik och behandling Lakartidningen. 112: 1857.  1
2014 Plavén-Sigray P, Gustavsson P, Farde L, Borg J, Stenkrona P, Nyberg L, Bäckman L, Cervenka S. Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study. Neuroimage. 102: 590-5. PMID 25134976 DOI: 10.1016/j.neuroimage.2014.08.018  1
2014 Fatouros-Bergman H, Cervenka S, Flyckt L, Edman G, Farde L. Meta-analysis of cognitive performance in drug-naïve patients with schizophrenia. Schizophrenia Research. 158: 156-62. PMID 25086658 DOI: 10.1016/j.schres.2014.06.034  1
2013 Cervenka S, Runeson B, Lönnqvist P, Hedlund A, Grönvall KE, Flyckt L. [Greater clarity on scientific competence is needed]. LäKartidningen. 110: 1416-7. PMID 23980385  1
2013 de Manzano Ö, Cervenka S, Jucaite A, Hellenäs O, Farde L, Ullén F. Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum. Neuroimage. 67: 1-6. PMID 23128075 DOI: 10.1016/j.neuroimage.2012.10.072  1
2013 Guterstam J, Jayaram-Lindström N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J. Effects of amphetamine on the human brain opioid system--a positron emission tomography study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 763-9. PMID 22932428 DOI: 10.1017/S1461145712000818  1
2013 Cervenka S, Runeson B, Lönnqvist P, Hedlund A, Grönvall KE, Flyckt L. Utbildningsaktiva inom psykiatrin om ST:Ökad tydlighet behövs om vetenskaplig kompetens Lakartidningen. 110: 6 1416.  1
2012 Cervenka S, Hedman E, Ikoma Y, Djurfeldt DR, Rück C, Halldin C, Lindefors N. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational Psychiatry. 2: e120. PMID 22832965 DOI: 10.1038/tp.2012.40  1
2012 Comley RA, Cervenka S, Palhagen SE, Panagiotidis G, Matthews JC, Lai RY, Halldin C, Farde L, Nichols TE, Whitcher BJ. A comparison of gray matter density in restless legs syndrome patients and matched controls using voxel-based morphometry. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 28-32. PMID 21091816 DOI: 10.1111/j.1552-6569.2010.00536.x  1
2010 de Manzano O, Cervenka S, Karabanov A, Farde L, Ullén F. Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. Plos One. 5: e10670. PMID 20498850 DOI: 10.1371/journal.pone.0010670  1
2010 Karabanov A, Cervenka S, de Manzano O, Forssberg H, Farde L, Ullén F. Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning. Proceedings of the National Academy of Sciences of the United States of America. 107: 7574-9. PMID 20368439 DOI: 10.1073/pnas.0911805107  1
2010 Cervenka S, Varrone A, Fransén E, Halldin C, Farde L. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans. Synapse (New York, N.Y.). 64: 478-85. PMID 20175222 DOI: 10.1002/syn.20765  1
2010 Cervenka S, Gustavsson JP, Halldin C, Farde L. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. Neuroimage. 50: 323-8. PMID 20004254 DOI: 10.1016/j.neuroimage.2009.12.006  1
2009 MacDonald SW, Cervenka S, Farde L, Nyberg L, Bäckman L. Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia. 47: 2299-304. PMID 19524093 DOI: 10.1016/j.neuropsychologia.2009.01.016  1
2008 Cervenka S, Lundberg J. [Representatives of the academic psychiatry have a responsibility]. LäKartidningen. 105: 652. PMID 18376717  1
2008 Cervenka S, Bäckman L, Cselényi Z, Halldin C, Farde L. Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. Neuroimage. 40: 1287-95. PMID 18296072 DOI: 10.1016/j.neuroimage.2007.12.063  1
2008 Cervenka S, Halldin C, Farde L. Age-related diurnal effect on D2 receptor binding: a preliminary PET study. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 671-8. PMID 18184446 DOI: 10.1017/S1461145707008358  1
2007 Cervenka S, Reutfors J, Lundberg J, Papadopoulos F, Lundén E, Sjöström C, Björklund L. [Coming generation of researchers--a question of fate for psychiatry]. LäKartidningen. 104: 2002-3. PMID 17639794  0.52
2006 Cervenka S, PÃ¥lhagen SE, Comley RA, Panagiotidis G, Cselényi Z, Matthews JC, Lai RY, Halldin C, Farde L. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain : a Journal of Neurology. 129: 2017-28. PMID 16816393 DOI: 10.1093/brain/awl163  1
2004 Talvik M, Nordström AL, Larsen NE, Jucaite A, Cervenka S, Halldin C, Farde L. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration. Psychopharmacology. 175: 148-53. PMID 15007534 DOI: 10.1007/s00213-004-1802-1  1
Show low-probability matches.